NIRS DEVICE WITH OPTICAL WAVELENGTH AND PATH LENGTH CORRECTION

• US 20130281803A1
• Filed: 04/18/2012
• Published: 10/24/2013
• Est. Priority Date: 04/18/2012
• Status: Active Grant

• Current Assignee: Fortiori Design LLC
• Original Assignee: Hutchinson Technology Incorporated (TDK Corporation)
• Inventors: Scheele, Bryan J., Schmitz, Roger W., Finstrom, Nicholas H.
• Granted Patent: US 9,907,494 B2
• Time in Patent Office: Days
• US Class Current: 600/323
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: A61B 5/14551 for measuring blood gases
• CPC Class Codes: A61B 5/14552 Details of sensors specially adapted therefor

Abstract

A near infrared spectrometer and method for wavelength and path length correction are disclosed. The spectrometer includes a number of photodiodes that transmit broadband near infrared measurement light into the tissue and at least one broadband detector which measures the light signal transmitted through the tissue. A processor estimates chromophore concentrations through a comparison of measured light attenuation and modeled light attenuation. The light attenuation model utilizes a light path length distribution derived from a Monte Carlo model and accounts for the spectral shape of the light source as a function of temperature.

Claims

1. A near infrared spectrometer for sensing tissue oxygen measurements in body tissue, comprising:

a plurality of light sources configured to emit broadband, near infrared measurement light into body tissue;

at least one broadband photodetector configured for sensing at least a portion of the measurement light reflected back from the body tissue;

a means for modeling light attenuations within the body tissue; and

a means for estimating at least one tissue chromophore concentration within the body tissue by comparing attenuations of the sensed measurement light reflected back from the body tissue to the modeled light attenuations.

2. The spectrometer of claim 1, wherein the means for modeling light attenuations includes a light attenuation model configured to sum the predicted attenuations of the light in tissue at a plurality of wavelength increments, wherein the wavelength increments are smaller than a spectral width of each light source and a responsivity of the at least one broadband photodetector.

3. The spectrometer of claim 2, further comprising a temperature sensor configured for sensing a temperature of the light sources.

4. The spectrometer of claim 3, wherein the light attenuation model is configured to compensate for a spectral shape of each light source based at least in part on the temperature.

5. The spectrometer of claim 4, wherein the spectral shape of each light source is pre-characterized at a plurality of temperatures.

6. The spectrometer of claim 5, wherein the spectral shape of each light source is interpolated or extrapolated from a plurality of pre-characterized temperatures.

7. The spectrometer of claim 2, wherein a path length distribution for each wavelength increment of the measurement light is predicted using a simulation model.

8. The spectrometer of claim 7, wherein the simulation model is a Monte Carlo model.

9. The spectrometer of claim 1, wherein the light sources are each coupled to a light mixer having an input end and an output end.

10. The spectrometer of claim 9, wherein the output end of the mixer is configured to couple directly to the tissue.

11. The spectrometer of claim 9, wherein the photodetector is configured to couple directly to the tissue.

12. The spectrometer of claim 1, further comprising a secondary photodetector configured for sensing the measurement light reflected back from the tissue.

13. The spectrometer of claim 12, wherein the secondary photodetector is configured for sensing at least a portion of the measurement light having a shorter optical path than an optical path of the measurement light sensed by the at least one broadband photodetector.

14. The spectrometer of claim 13, wherein the at least one broadband photodetector and feedback photodetector are coupled directly to the tissue and are configured to obtain reflectance mode measurements of the measurement light within the tissue.

15. A near infrared spectrometer for sensing tissue oxygen measurements in body tissue, comprising:

a plurality of light sources configured to emit broadband, near infrared measurement light into body tissue;

at least one broadband photodetector configured for sensing at least a portion of the measurement light reflected back from the body tissue;

at least one temperature sensor configured for sensing a temperature of the light sources;

a light attenuation model configured for modeling light attenuations within the body tissue based at least in part on the temperature sensed by the temperature sensor;

a processor configured for estimating at least one tissue chromophore concentration within the body tissue by comparing attenuations of the sensed measurement light reflected back from the body tissue to modeled light attenuations from the light attenuation model; and

wherein the processor is configured to sum the attenuations of the light in tissue at a plurality of wavelength increments, the wavelength increments being smaller than a spectral width of each light source and a responsivity of the at least one broadband photodetector.

16. A method for determining one or more tissue oxygen measurements in body tissue, the method comprising:

coupling a spectrometer to a tissue of interest, the spectrometer including a plurality of light sources configured to emit broadband, near infrared measurement light into the body tissue and at least one broadband photodetector configured for sensing at least a portion of the measurement light reflected back from the body tissue;

measuring the attenuation of the measurement light reflected back from the body tissue;

predicting light attenuation within the body tissue using a light attenuation model, wherein the light attenuation model is configured to sum the predicted attenuations of light in tissue at a plurality of wavelength increments, the wavelength increments being smaller than a spectral width of each light source and a responsivity of the at least one broadband photodetector; and

estimating at least one tissue chromophore concentration within the body tissue by comparing the attenuation of the measurement light reflected back from the body tissue to the predicted light attenuation.

17. The method of claim 16, further comprising sensing a temperature of each light source, and wherein the light attenuation model is configured to compensate for a spectral shape of each light source based at least in part on the temperature.

18. The method of claim 17, wherein predicting light attenuations within the body includes pre-characterizing the spectral shape of each light source at a plurality of temperatures.

19. The method of claim 17, wherein predicting light attenuations within the body includes normalizing an intensity distribution based on a peak intensity and interpolating or extrapolating a spectral shape of each light source along a line of uniform intensity.

20. The method of claim 17, wherein predicting light attenuations within the body tissue using a light attenuation model includes simulating the path lengths of measurement light within the tissue using a simulation model.